Medical Animation & Scientific Storytelling

## Helix Animation Solutions

Helix Animation Solutions is a medical animation and scientific storytelling studio that produces visualizations for pharmaceutical companies, consumer health brands, and medical device manufacturers. The company operates under the domain helixanimation.com and positions itself as a specialist in translating complex clinical and scientific content into screen-ready visual assets. Based on available research, Helix works with global clients, though the specific headquarters city and country are not publicly confirmed in the materials reviewed here.

### What They Actually Do

Helix's core output is medical animation and scientific storytelling. In practice, this covers a range of deliverable types: mechanism-of-action (MOA) videos, 3D visualizations built from real clinical data (including STL files from intraoral scanners, for example), educational videos for healthcare professionals, and brand campaign content for consumer health companies. Beyond traditional animation, they also produce augmented reality (AR) and virtual reality (VR) concepts, as well as interactive experiences.

One testimonial from a clinical education manager at a dental technology company describes Helix transforming "real clinical STL data into highly realistic 3D visualizations" for intraoral scanning education, which gives a concrete sense of their technical depth. Another client, a communications specialist in spatial biology, notes that Helix was "the only company that fully understood the complexities of capturing spatial biology." These are not generic animation deliverables. They require scientific literacy, domain-specific research, and a QA process that checks accuracy, not just aesthetics.

The studio also handles augmented reality concepts alongside linear video, which suggests some capacity for interactive formats. Whether that scales to full AR/VR deployment or stays at concept and prototype level is worth confirming directly on a buyer call.

### Who They Serve

The client list, based on publicly available testimonials and references, includes P&G, NAOS, and several unnamed pharmaceutical and medical device companies. Named contacts include a brand director, a brand campaign and content manager, a senior manager of clinical education strategy for North America, and an international commercial director at a healthcare VMS company. That spread tells you the buyer profile: marketing and medical education teams inside mid-to-large pharma and med device companies who need scientifically accurate content that also works commercially.

Helix describes itself as trusted by "global pharma, consumer health, and med device leaders." The testimonials are from North American and European contacts, suggesting international delivery capability. Exact geographic breakdown of the client base is not confirmed, so ask where most active accounts sit.

The studio has received awards for its work, which it references in its 2025 showreel. The specific awards are not named in available materials, so I would not treat this as a differentiator until you can confirm which industry bodies recognized the work and for what.

### Practical Delivery Details

Helix does not publish pricing, minimum engagement size, or team headcount in its public-facing content. The testimonials consistently reference responsiveness, accurate feedback turnaround, and comprehensive project timelines, which are positive signals on project management maturity. Whether they have a formal QA review stage built into the animation process, or whether accuracy review is ad hoc and client-driven, is not clear from public materials. That is one of the first questions I would ask.

The studio lists a showreel, case studies, and a jobs page, which suggests it is an operating studio with ongoing hiring, not an one-person shop. Exact headcount is not published. Pricing model is also not disclosed publicly. Given the project-based nature of animation work and the scope of most medical visualization projects, a project-based commercial model is the most likely structure, but confirm before scoping.

Language of delivery appears to be English based on all available testimonials and site content, though international clients are referenced.

### Compliance and Regulated-Industry Considerations

Medical animation for pharma, consumer health, and medical device companies touches regulated content. Scripts and visuals may need to align with medical-legal-regulatory (MLR) review processes at the client end. Helix does not publish certifications such as ISO 27001, HIPAA, or SOC 2 in available materials. If your content involves proprietary compound data, clinical trial visuals, or pre-launch product information, ask explicitly about their data handling practices and NDA protocol. This is not a knock on Helix; most boutique animation studios operate under client-specific NDAs rather than third-party certifications. But for a regulated buyer, you need to verify this before sharing sensitive pipeline assets.

### Editor's Take

Helix Animation Solutions fits best for healthcare marketing and medical education teams that need scientifically credible, visually polished content and have a clear brief to hand. The testimonials consistently praise accuracy, responsiveness, and collaboration, which are the three things that matter most when you are trying to get complex science through a MLR review without multiple revision cycles.

I would not use Helix if you are looking for a general-purpose content production house or a low-cost video vendor. Their positioning is specialist. Specialist studios tend to have fewer agents working in parallel and a tighter production pipeline, which means capacity matters. Ask directly about current project load and realistic lead times before you commit to a launch date.

The things I would verify on a first call: who reviews scientific accuracy internally (is there a medical writer or scientific reviewer on staff, or does that sit entirely with the client?), what the revision process looks like at each production stage, and whether they have handled content subject to MLR or similar regulatory review before. If they have, they will know what you mean immediately. If they have not, that is a real operational risk for a pharma or med device buyer, regardless of how strong the visuals look.